Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
DGX compared with MGX: revenue, margins and what each company keeps, and the suppliers and customers both name
DGX
Quest Diagnostics Inc
Change
Mkt cap
Revenue
Revenue
MGX
Metagenomi Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
DGX
Quest Diagnostics Inc
vs
MGX
Metagenomi Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
DGX, solid
MGX, dashed
Supply-chain overlap
Revenue flow
MGX: latest quarter is a loss; flow not drawable.
Method
›
DGX
Quest Diagnostics Inc
Change
257.65
▲
+1.14%
· post 257.66
Mkt cap
$28.1B
Revenue
$3.1B
Q3 FY26
Revenue
$11.0B
FY25
MGX
Metagenomi Therapeutics, Inc.
Change
0.71
▼
−3.12%
· post 0.71
Closed
Nov 6 '26
Mkt cap
$26.8M
Revenue
$1M
Q1 FY26
Revenue
$25M
FY25
vs
Compare
Closed
Nov 6 '26
DGX
Quest Diagnostics Inc
vs
MGX
Metagenomi Therapeutics, Inc.
257.65
▲
+1.14%
post 257.66
Price
0.71
▼
−3.12%
post 0.71
$28.1B
Mkt cap
$26.8M
Q3 FY26
$3.1B
Revenue
$1M
Q1 FY26
FY25
$11.0B
Revenue
$25M
FY25
Change
Change
DGX
257.65
▲
+1.14%
vs
MGX
0.71
▼
−3.12%
Closed
Nov 6 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only DGX
1
GRAL
Grail
customer
Shared
0
No shared counterparties.
Only MGX
2
IONS
Ionis Pharmaceuticals
customer
—
Acuitas Therapeutics
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR